Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from rmo Fisher Scientific

Family of Henrietta Lacks asks court to reject Thermo Fisher’s second motion to dismiss lawsuit

BALTIMORE — Family members of Henrietta Lacks are asking a federal judge to reject Thermo Fisher Scientific’s second attempt to get the court to dismiss the family’s lawsuit against the multimillion-dollar biotech company.

Tribune News Service

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover

Catalent stock launched higher Monday on a rumor that Danaher could acquire it in a bid to compete with Thermo Fisher Scientific.

Investors Business Daily

Layoffs mount: Twitter, tech, biotech firms chop 900-plus Bay Area jobs

SAN JOSE, California — Twitter and other companies have unveiled plans to chop more than 900 Bay Area jobs in a fresh round of tech and biotech layoffs that could jolt the region’s increasingly wobbly economy.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Block, Eli Lilly And 2 Other Stocks Insiders Are Selling

The US economy added 261,000 jobs in October, while the unemployment rate increased to 3.7% during the month. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Binding Site sold in £2.25bn deal

Company which specialises in diagnostic tools has been sold by its PE backers after an 11-year relationship

Birmingham Post

Check Out What Whales Are Doing With TMO

A whale with a lot of money to spend has taken a noticeably bullish stance on Thermo Fisher Scientific. Looking at options history for Thermo Fisher Scientific (NYSE:TMO) we detected 10 strange trades.

Benzinga

Check Out What Whales Are Doing With TMO

Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Check Out What Whales Are Doing With TMO

Benzinga

Check Out What Whales Are Doing With Thermo Fisher Scientific

Benzinga

Check Out What Whales Are Doing With TMO

Benzinga

What Are Whales Doing With Thermo Fisher Scientific

Benzinga

Analyzing Thermo Fisher Scientific's Short Interest

Thermo Fisher Scientific's (NYSE:TMO) short percent of float has fallen 3.45% since its last report. The company recently reported that it has 3.30 million shares sold short, which is 0.84% of all regular shares that are available for trading.

Benzinga

Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 15.14% on an annualized basis producing an average annual return of 25.61%. Currently, Thermo Fisher Scientific has a market capitalization of $198.20 billion.

Benzinga

What Are Whales Doing With Thermo Fisher Scientific

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Here's How Much $100 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 27.09%. Currently, Thermo Fisher Scientific has a market capitalization of $218.08 billion.

Benzinga

Check Out What Whales Are Doing With TMO

Someone with a lot of money to spend has taken a bullish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Tribune News Service

Court to consider whether Henrietta Lacks’ family’s ‘unprecedented’ lawsuit over use of her cells can continue

BALTIMORE — A federal judge will decide whether the family of Henrietta Lacks has enough legal standing to continue its lawsuit against the biotech company Thermo Fisher Scientific after the two sides argued in court Tuesday about the use of cells taken from Lacks more than 70 years ago.

Benzinga

Wells Fargo And 3 Other Stocks Insiders Are Selling

Gold futures traded slightly higher on Friday. Investors, meanwhile, focused on some notable insider trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Thermo Fisher Scientific vs. Agilent Technologies: Which Diagnostics & Research Stock is a Better Buy?

Integration of advanced technologies and analytics to early diagnosis of chronic diseases have helped companies engaged in the medical diagnostics and research industry gain wide market reach. This growing demand and rising investments should help prominent players in this space, Thermo Fisher Scientific (TMO) and Agilent Technologies (A), benefit. But…

Benzinga

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 10.0% on an annualized basis producing an average annual return of 16.91%. Currently, Thermo Fisher Scientific has a market capitalization of $213.80 billion.

The Hindu

Thermo Fisher opens R&D facility in Hyderabad

IEC plans to invest $15 million annually

Benzinga

Thermo Fisher Scientific: Q1 Earnings Insights

Thermo Fisher Scientific (NYSE:TMO) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga

Earnings Preview: Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE:TMO) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Thermo Fisher Scientific will report an earnings per share (EPS) of $6.18.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Benzinga

If You Invested $100 In Thermo Fisher Scientific 5 Years Ago, Here's How Much You Would Have Today

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 5 years by 16.55% on an annualized basis producing an average annual return of 29.85%. Currently, Thermo Fisher Scientific has a market capitalization of $229.51 billion.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.